Escalon Medical logo

ESMC - Escalon Medical Share Price

$0.198 0.1  58.3%

Last Trade - 02/07/20

Micro Cap
Market Cap £1.18m
Enterprise Value £1.31m
Revenue £7.74m
Position in Universe 6041st / 6344
Unlock ESMC Revenue
Relative Strength (%)
1m +31.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.00%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
12.4 13.1 11.6 11.2 11.4 9.63 -4.9%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 March 2020, Escalon Medical Corp. revenues increased 1% to $7.4M. Net loss applicable to common stockholders decreased 22% to $221K. Revenues reflect Service plans increase of 4% to $718K, Products remaining flat at $6.7M. Lower net loss reflects Other income increase from $11K to $759K (income), Marketing, general and administrative decrease of 6% to $3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ESMC Revenue Unlock ESMC Revenue

Net Income

ESMC Net Income Unlock ESMC Revenue

Normalised EPS

ESMC Normalised EPS Unlock ESMC Revenue

PE Ratio Range

ESMC PE Ratio Range Unlock ESMC Revenue

Dividend Yield Range

ESMC Dividend Yield Range Unlock ESMC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ESMC EPS Forecasts Unlock ESMC Revenue
Profile Summary

Escalon Medical Corp. operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. Its color/fluorescein angiography digital imaging system is designed for ophthalmology. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery.

Last Annual June 30th, 2019
Last Interim March 31st, 2020
Incorporated September 27, 2001
Public Since September 11, 1992
No. of Shareholders: n/a
No. of Employees: 57
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange OTC Markets Group
Shares in Issue 7,415,329
Free Float (0.0%)
Eligible for
ESMC Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ESMC
Upcoming Events for ESMC
Frequently Asked Questions for Escalon Medical
What is the Escalon Medical share price?

As of 02/07/20, shares in Escalon Medical are trading at $0.198, giving the company a market capitalisation of £1.18m. This share price information is delayed by 15 minutes.

How has the Escalon Medical share price performed this year?

Shares in Escalon Medical are currently trading at $0.198 and the price has moved by 65% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Escalon Medical price has moved by 65.48% over the past year.

What are the analyst and broker recommendations for Escalon Medical?

There are no analysts currently covering Escalon Medical.

When will Escalon Medical next release its financial results?

Escalon Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Escalon Medical dividend yield?

Escalon Medical does not currently pay a dividend.

Does Escalon Medical pay a dividend?

Escalon Medical does not currently pay a dividend.

When does Escalon Medical next pay dividends?

Escalon Medical does not currently pay a dividend.

How do I buy Escalon Medical shares?

To buy shares in Escalon Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Escalon Medical?

Shares in Escalon Medical are currently trading at $0.198, giving the company a market capitalisation of £1.18m.

Where are Escalon Medical shares listed? Where are Escalon Medical shares listed?

Here are the trading details for Escalon Medical:

Country of listing: United States
Exchange: OTC
Ticker Symbol: ESMC
What kind of share is Escalon Medical?

Based on an overall assessment of its quality, value and momentum, Escalon Medical is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Escalon Medical share price forecast 2020?

We were not able to load any forecast data for Escalon Medical.

How can I tell whether the Escalon Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Escalon Medical. Over the past six months, the relative strength of its shares against the market has been 24.87%. At the current price of $0.198, shares in Escalon Medical are trading at 46.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Escalon Medical PE Ratio?

The Escalon Medical PE ratio based on its reported earnings over the past 12 months is 11.61. The shares are currently trading at $0.198.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Escalon Medical?

Escalon Medical's management team is headed by:

Richard DePiano - CHM
Mark Wallace - CFO
C. Todd Trusk - DRC
Richard DePiano - PRE
Fred Choate - IND
David Jacovini - DRC
John Dogum - DRC
Lisa Napolitano - IND
Who are the major shareholders of Escalon Medical?

Here are the top five shareholders of Escalon Medical based on the size of their shareholding:

DePiano (Richard J) Individual Investor
Percentage owned: 1.9% (141k shares)
Invesco Wilshire Micro-Cap ETF Mutual Fund
Percentage owned: 0.02% (1.73k shares)
Victory Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 0.02% (1.29k shares)
Master Extended Market Index Series-Quantitative Master Seri Mutual Fund
Percentage owned: 0.02% (1.29k shares)
Invesco Capital Management LLC Investment Advisor
Percentage owned: 0.02% (1.73k shares)
Similar to ESMC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.